Florian Märkl

539 total citations
8 papers, 140 citations indexed

About

Florian Märkl is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Florian Märkl has authored 8 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Florian Märkl's work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (3 papers) and CRISPR and Genetic Engineering (2 papers). Florian Märkl is often cited by papers focused on CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (3 papers) and CRISPR and Genetic Engineering (2 papers). Florian Märkl collaborates with scholars based in Germany, United States and France. Florian Märkl's co-authors include Sebastian Kobold, Stefan Endres, Duc Huynh, Pia Winter, Daria Briukhovetska, Matthias Seifert, Mohamed-Reda Benmebarek, Bruno L. Cadilha, Ruth Grünmeier and Tobias Feuchtinger and has published in prestigious journals such as Blood, British Journal of Cancer and Cancer Immunology Immunotherapy.

In The Last Decade

Florian Märkl

7 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Märkl Germany 4 97 88 29 22 13 8 140
Patrick Innamarato United States 8 118 1.2× 100 1.1× 33 1.1× 28 1.3× 19 1.5× 18 189
Rachel Marcone Switzerland 5 95 1.0× 100 1.1× 54 1.9× 15 0.7× 11 0.8× 9 163
Siham Farhane France 6 105 1.1× 70 0.8× 25 0.9× 27 1.2× 20 1.5× 7 162
Patrick Layritz Germany 3 108 1.1× 93 1.1× 26 0.9× 20 0.9× 11 0.8× 4 144
Cristina F. Contreras United States 4 110 1.1× 101 1.1× 42 1.4× 22 1.0× 11 0.8× 4 186
Christine M. Minnar United States 6 96 1.0× 119 1.4× 49 1.7× 15 0.7× 17 1.3× 14 195
Daulet Satpayev United States 4 136 1.4× 116 1.3× 30 1.0× 21 1.0× 10 0.8× 7 178
L. Resano Spain 3 110 1.1× 117 1.3× 40 1.4× 14 0.6× 15 1.2× 5 158
Jessica S.W. Borgers Netherlands 8 115 1.2× 110 1.3× 44 1.5× 11 0.5× 18 1.4× 13 197
Marit J van Elsas Netherlands 7 129 1.3× 164 1.9× 54 1.9× 17 0.8× 19 1.5× 8 236

Countries citing papers authored by Florian Märkl

Since Specialization
Citations

This map shows the geographic impact of Florian Märkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Märkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Märkl more than expected).

Fields of papers citing papers by Florian Märkl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Märkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Märkl. The network helps show where Florian Märkl may publish in the future.

Co-authorship network of co-authors of Florian Märkl

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Märkl. A scholar is included among the top collaborators of Florian Märkl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Märkl. Florian Märkl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Rohrbacher, Lisa, Daniel Nixdorf, Bettina Brauchle, et al.. (2025). FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion. Blood Advances. 10(4). 1179–1193.
2.
Stock, Sophia, Adrian Gottschlich, Janina Dörr, et al.. (2024). Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma. Cancer Immunology Immunotherapy. 73(6). 100–100. 2 indexed citations
3.
Rohrbacher, Lisa, Daniel Nixdorf, Bettina Brauchle, et al.. (2023). Two Players, One Goal: BiTE ® Vs CART Targeting FLT3 in AML. Blood. 142(Supplement 1). 3444–3444. 1 indexed citations
4.
Cadilha, Bruno L., Mohamed-Reda Benmebarek, Florian Märkl, et al.. (2023). Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy. British Journal of Cancer. 129(4). 696–705. 10 indexed citations
5.
Marcinek, Anetta, Bettina Brauchle, Lisa Rohrbacher, et al.. (2023). CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells. Cancer Immunology Immunotherapy. 72(7). 2499–2512. 4 indexed citations
6.
Huynh, Duc, Pia Winter, Florian Märkl, Stefan Endres, & Sebastian Kobold. (2022). Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment. Seminars in Immunopathology. 45(2). 215–227. 12 indexed citations
7.
Märkl, Florian, Duc Huynh, Stefan Endres, & Sebastian Kobold. (2022). Utilizing chemokines in cancer immunotherapy. Trends in cancer. 8(8). 670–682. 110 indexed citations
8.
Rohrbacher, Lisa, Daniel Nixdorf, Bettina Brauchle, et al.. (2022). The Race Is on: BiTE Vs CART As FLT3-Directed Immunotherapies in AML. Blood. 140(Supplement 1). 10233–10234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026